1. null
   Lori E. Lowes et al, 2017 CrossRef
2. CUL4B promotes metastasis and proliferation in pancreatic cancer cells by inducing epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway
   Yue-Ming He et al, 2018, J. Cell. Biochem. CrossRef
3. The Kraken Wakes: induced EMT as a driver of tumour aggression and poor outcome
   Andrew D. Redfern et al, 2018, Clin Exp Metastasis CrossRef
4. Epithelial–mesenchymal-transition-inducing transcription factors: new targets for tackling chemoresistance in cancer?
   Jente van Staalduinen et al, 2018, Oncogene CrossRef
5. Intermediate Filaments as Effectors of Cancer Development and Metastasis: A Focus on Keratins, Vimentin, and Nestin
   Pooja Sharma et al, 2019, Cells CrossRef
6. The therapeutic potential of targeting the epithelial–mesenchymal transition in cancer
   Kevin R Ginnebaugh et al, 2014, Expert Opinion on Therapeutic Targets CrossRef
7. Tumor Cell Heterogeneity in Small Cell Lung Cancer (SCLC): Phenotypical and Functional Differences Associated with Epithelial-Mesenchymal Transition (EMT) and DNA Methylation Changes
   Alexander Krohn et al, 2014, PLoS ONE CrossRef
8. A literature mining-based approach for identification of cellular pathways associated with chemoresistance in cancer
   Jung Hun Oh et al, 2016, Brief Bioinform CrossRef
9. Controversies around epithelial–mesenchymal plasticity in cancer metastasis
   Elizabeth D. Williams et al, 2019, Nat Rev Cancer CrossRef
10. Expression of Epithelial-Mesenchymal Transition Markers in Treated Pancreatic Ductal Adenocarcinoma
    Minhua Wang et al, 2019, Pancreas CrossRef
11. LTBP1 promotes esophageal squamous cell carcinoma progression through epithelial-mesenchymal transition and cancer-associated fibroblasts transformation
    Rui Cai et al, 2020, J Transl Med CrossRef
12. Prognostic significance of ZEB1 and ZEB2 in digestive cancers: a cohort-based analysis and secondary analysis
    Huihui Chen et al, 2017, Oncotarget CrossRef
13. null
    Annamarie C. Dalton et al, 2021 CrossRef
14. Effects of Chemotherapy for Metastatic Colorectal Cancer on the TGF-β Signaling and Related miRNAs hsa-miR-17-5p, hsa-miR-21-5p and hsa-miR-93-5p
    Jovana Despotovic et al, 2021, Cell Biochem Biophys CrossRef
15. Cultivation of Head and Neck Squamous Cell Carcinoma Cells with Wound Fluid Leads to Cisplatin Resistance via Epithelial-Mesenchymal Transition Induction
    Till Jasper Meyer et al, 2021, IJMS CrossRef
16. The pan-cancer landscape of crosstalk between epithelial-mesenchymal transition and immune evasion relevant to prognosis and immunotherapy response
    Guangyu Wang et al, 2021, npj Precis. Onc. CrossRef
17. Dynamic EMT: a multi‐tool for tumor progression
    Simone Brabletz et al, 2021, EMBO J CrossRef
18. Role of p38 MAP kinase in cancer stem cells and metastasis
    Sriya Kudaravalli et al, 2022, Oncogene CrossRef
19. Omics Analysis of Chemoresistant Triple Negative Breast Cancer Cells Reveals Novel Metabolic Vulnerabilities
    Dimitris Kordias et al, 2022, Cells CrossRef
20. 3-Bromopyruvate Suppresses the Malignant Phenotype of Vemurafenib-Resistant Melanoma Cells
    Patrik da Silva Vital et al, 2022, IJMS CrossRef
21. An Overview of Epithelial-to-Mesenchymal Transition and Mesenchymal-to-Epithelial Transition in Canine Tumors: How Far Have We Come?
    Federico Armando et al, 2022, Veterinary Sciences CrossRef
22. Three-Course Neoadjuvant Chemotherapy Associated with Unfavorable Survival of Non-responders to the First Two Courses for Locally Advanced Esophageal Cancer
    Yuto Kubo et al, 2023, Ann Surg Oncol CrossRef
23. Zinc finger proteins and ATP‐binding cassette transporter‐dependent multidrug resistance
    Sanaz Barzegar et al, 2023, Eur J Clin Investigation CrossRef
24. Mutual regulation of TGFβ-induced oncogenic EMT, cell cycle progression and the DDR
    Harald Schuhwerk et al, 2023, Seminars in Cancer Biology CrossRef